Correlation Between Loncar Cancer and Amplify

Can any of the company-specific risk be diversified away by investing in both Loncar Cancer and Amplify at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Loncar Cancer and Amplify into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Loncar Cancer Immunotherapy and Amplify, you can compare the effects of market volatilities on Loncar Cancer and Amplify and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Loncar Cancer with a short position of Amplify. Check out your portfolio center. Please also check ongoing floating volatility patterns of Loncar Cancer and Amplify.

Diversification Opportunities for Loncar Cancer and Amplify

-0.34

Correlation Coefficient

Loncar Cancer  Amplify

Very good diversification

The 3 months correlation between Loncar and Amplify is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Loncar Cancer Immunotherapy and Amplify in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amplify and Loncar Cancer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Loncar Cancer Immunotherapy are associated (or correlated) with Amplify. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amplify has no effect on the direction of Loncar Cancer i.e., Loncar Cancer and Amplify go up and down completely randomly.

Pair Corralation between Loncar Cancer and Amplify

If you would invest  1,916  in Amplify on October 10, 2024 and sell it today you would earn a total of  0.00  from holding Amplify or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	2.5%
Values	Daily Returns

Loncar Cancer Immunotherapy  vs.  Amplify

Loncar Cancer Immuno

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Loncar Cancer Immunotherapy has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unsteady performance, the Etf's fundamental indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the ETF retail investors.

Amplify

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Amplify has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Amplify is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Loncar Cancer and Amplify

The main advantage of trading using opposite Loncar Cancer and Amplify positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Loncar Cancer position performs unexpectedly, Amplify can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amplify will offset losses from the drop in Amplify's long position.

The idea behind Loncar Cancer Immunotherapy and Amplify pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.